- Report
- January 2026
- 197 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 191 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 199 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 181 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 183 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 188 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- January 2026
- 188 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- August 2025
- 186 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- August 2025
- 187 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- May 2026
- 396 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 467 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 392 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 499 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 192 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 485 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 274 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 402 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 467 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 366 Pages
Global
From €5135EUR$5,850USD£4,441GBP
- Report
- May 2026
- 407 Pages
Global
From €5135EUR$5,850USD£4,441GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more